Below are the most recent publications written about "Cardiomegaly" by people in Profiles.
-
Droste P, Wong DWL, Hohl M, von Stillfried S, Klinkhammer BM, Boor P. Semiautomated pipeline for quantitative analysis of heart histopathology. J Transl Med. 2023 09 26; 21(1):666.
-
Moellmann J, Mann PA, Kappel BA, Kahles F, Klinkhammer BM, Boor P, Kramann R, Ghesquiere B, Lebherz C, Marx N, Lehrke M. The sodium-glucose co-transporter-2 inhibitor ertugliflozin modifies the signature of cardiac substrate metabolism and reduces cardiac mTOR signalling, endoplasmic reticulum stress and apoptosis. Diabetes Obes Metab. 2022 11; 24(11):2263-2272.
-
Kindermann W, Urhausen A, Scharhag J. Comment on: "Athlete's Heart: Diagnostic Challenges and Future Perspectives". Sports Med. 2019 03; 49(3):493-494.
-
Kindermann W, Urhausen A, Scharhag J. Comment on: Athlete's Heart: Is the Morganroth Hypothesis Obsolete? Heart Lung Circ. 2019 02; 28(2):e12-e13.
-
Abuzaid AS, Hamid SA, Gakhal M, Weiss S, Horn R, Weintraub W. Not All Chest Pains Are Made Equal: A Case of Apica Hypertrophic Cardiomyopathy. Del Med J. 2017 Feb; 89(2):54-56.
-
Beetz N, Rommel C, Schnick T, Neumann E, Lother A, Monroy-Ordonez EB, Zeeb M, Preissl S, Gilsbach R, Melchior-Becker A, Rylski B, Stoll M, Schaefer L, Beyersdorf F, Stiller B, Hein L. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload. J Mol Cell Cardiol. 2016 Dec; 101:145-155.
-
Omede A, Zi M, Prehar S, Maqsood A, Stafford N, Mamas M, Cartwright E, Oceandy D. The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice. Biochem Biophys Res Commun. 2016 Oct 28; 479(4):708-714.
-
Traynham CJ, Cannavo A, Zhou Y, Vouga AG, Woodall BP, Hullmann J, Ibetti J, Gold JI, Chuprun JK, Gao E, Koch WJ. Differential Role of G Protein-Coupled Receptor Kinase 5 in Physiological Versus Pathological Cardiac Hypertrophy. Circ Res. 2015 Dec 04; 117(12):1001-12.
-
Watson CJ, Horgan S, Neary R, Glezeva N, Tea I, Corrigan N, McDonald K, Ledwidge M, Baugh J. Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis. J Cardiovasc Pharmacol Ther. 2016 Jan; 21(1):127-37.
-
Topcuoglu S, Karatekin G, Yavuz T, Arman D, Kaya A, Gursoy T, Ovali F. The relationship between the oxidative stress and the cardiac hypertrophy in infants of diabetic mothers. Diabetes Res Clin Pract. 2015 Jul; 109(1):104-9.